Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Translational Psychiatry
|
December 1, 2021
Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
Paul Allen, Emily J Hird, Natasza Orlov, et al.
Translational Psychiatry
|
November 11, 2021
Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
Paul Allen, Emily J Hird, Natasza Orlov, et al.
Archives of General Psychiatry
|
January 7, 2009
Elevated striatal dopamine function linked to prodromal signs of schizophrenia
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, et al.
Neuroimage
|
April 5, 2008
Abnormal P300 in people with high risk of developing psychosis
Elvira Bramon, Madiha Shaikh, Matthew Broome, et al.
The International Journal of Neuropsychopharmacology
|
October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms
Gemma Modinos, Fatma Simsek, Jamie Horder, et al.
Nano Letters
|
April 24, 2020
Ultrafast Optoelectronic Processes in 1D Radial van der Waals Heterostructures: Carbon, Boron Nitride, and MoS<sub>2</sub> Nanotubes with Coexisting Excitons and Highly Mobile Charges
Maria G Burdanova, Reza J Kashtiban, Yongjia Zheng, et al.
Schizophrenia Bulletin
|
September 1, 2011
Effect of DISC1 on the P300 waveform in psychosis
Madiha Shaikh, Mei-Hua Hall, Katja Schulze, et al.
Health Technology Assessment (Winchester, England)
|
January 26, 2021
Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT
Anthony P Morrison, Melissa Pyle, Rory Byrne, et al.
Trials
|
November 6, 2025
A randomised controlled trial to evaluate the clinical and cost-effectiveness of Stimulant compared with Non-stimulant medication for adults with Attention-deficit/hyperactivity disorder and a history of Psychosis or biPolar disordER: SNAPPER
Shrushma Loi, Paras Joshee, Ryan Ottridge, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 15, 2026
New approaches to clinical research for people with schizophrenia
Katherine Beck, Matthew Broome, Saeed Farooq, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Translational Psychiatry
|
December 1, 2021
Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
Paul Allen, Emily J Hird, Natasza Orlov, et al.
Translational Psychiatry
|
November 11, 2021
Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
Paul Allen, Emily J Hird, Natasza Orlov, et al.
Archives of General Psychiatry
|
January 7, 2009
Elevated striatal dopamine function linked to prodromal signs of schizophrenia
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, et al.
Neuroimage
|
April 5, 2008
Abnormal P300 in people with high risk of developing psychosis
Elvira Bramon, Madiha Shaikh, Matthew Broome, et al.
The International Journal of Neuropsychopharmacology
|
October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms
Gemma Modinos, Fatma Simsek, Jamie Horder, et al.
Nano Letters
|
April 24, 2020
Ultrafast Optoelectronic Processes in 1D Radial van der Waals Heterostructures: Carbon, Boron Nitride, and MoS<sub>2</sub> Nanotubes with Coexisting Excitons and Highly Mobile Charges
Maria G Burdanova, Reza J Kashtiban, Yongjia Zheng, et al.
Schizophrenia Bulletin
|
September 1, 2011
Effect of DISC1 on the P300 waveform in psychosis
Madiha Shaikh, Mei-Hua Hall, Katja Schulze, et al.
Health Technology Assessment (Winchester, England)
|
January 26, 2021
Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT
Anthony P Morrison, Melissa Pyle, Rory Byrne, et al.
Trials
|
November 6, 2025
A randomised controlled trial to evaluate the clinical and cost-effectiveness of Stimulant compared with Non-stimulant medication for adults with Attention-deficit/hyperactivity disorder and a history of Psychosis or biPolar disordER: SNAPPER
Shrushma Loi, Paras Joshee, Ryan Ottridge, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 15, 2026
New approaches to clinical research for people with schizophrenia
Katherine Beck, Matthew Broome, Saeed Farooq, et al.
Page
of 6